Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high‐bleeding risk procedure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high‐bleeding risk procedure

Published:2022-03-02 Issue:5 Volume:36 Page:898-907
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Gibert Audrick¹^ORCID,Lanoiselée Julien¹²^ORCID,Janisset Luc³,Pernod Gilles⁴,Ollier Edouard¹^ORCID,Delavenne Xavier¹⁵^ORCID

Affiliation:

1. INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase Université de Lyon Saint‐Etienne France

2. Departement d'Anesthésie Réanimation CHU de Saint‐Etienne Saint‐Etienne France

3. Service des Urgences CHU de Saint‐Etienne Saint‐Etienne France

4. Service de Médecine Vasculaire Grenoble France

5. Laboratoire de Pharmacologie Toxicologie CHU de Saint‐Etienne Saint‐Etienne France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12770

Reference25 articles.

1. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

2. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

3. Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP